| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | Director | Buy | 95.0 | +5,000 | 23.83% | ✗ | $50K |
| Jun 22, 2015 | Jun 24, 2015 | Vaxart, Inc. | Director | Buy | 95.0 | +35,000 | 100.00% | ✗ | $76.9K |